Agile Therapeutics, Inc. (AGRX) stock declined over -45.03% intraday to trade at $0.64 a share on NASDAQ. The stock opened with a loss of -55.24% at $0.705 and touched an intraday high of $0.705, falling -45.06% against the last close of $1.165. The stock went to a low of $0.61 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue5.75 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Agile Therapeutics, Inc. (NASDAQ: AGRX) stock price is $0.64 as of the last check on Friday, July 1. During the trading session, AGRX stock reached the peak price of $0.705 while $0.61 was the lowest point it dropped to.
The NASDAQ listed AGRX is part of Pharmaceuticals industry that operates in the broader Health Care sector. Agile Therapeutics, Inc. , a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States.
Mr. Alfred F. Altomari
Chairman & CEO
Mr. Dennis P. Reilly
Sr. VP & CFO
Mr. Geoffrey P. Gilmore
Sr. VP, Gen. Counsel & Corp. Sec.
VP & Chief Accounting Officer
AGRX stock traded closed the last session at $0.64, which is $-0.52 or -45.03% lower than its previous close of $1.165. AGRX's current trading price is -41.25% lower than its 52-week high of $55.60 where as its distance from 52-week low of 1.09% is -98.85%.
Number of AGRX employees currently stands at -. AGRX operates from 500 College Road East, Suite 310, Princeton, NJ 08540, United States.
Official Webiste of $AGRX is: https://www.agiletherapeutics.com
AGRX stock volume for the day was 49,315,724 shares while in the previous session number of AGRX shares traded was 49,710,000 . The average number of AGRX shares traded daily for last 3 months was 6.24 Million.
The percentage change in AGRX stock occurred in the recent session was -45.03% while the dollar amount for the price change in AGRX stock was $-0.52.
In the recent session, the day high for AGRX stock was $0.705 while the low for AGRX stock touched on the day was $0.61.
The market value of AGRX currently stands at 5.3 Million with its latest stock price at $0.64 and 4.54 Million of its shares outstanding.